Generalized Anxiety Disorder Test (GAD-7): Free Self-Assessment

This free anxiety self-assessment is based on the GAD-7, a validated screening tool used by clinicians worldwide. Answer 7 questions, get your score instantly, and see what your results may mean for your next step.

Jump To Section

Therapist taking notes during a GAD-7 anxiety screening assessment with a client at a mental health clinic.

This screening tool is based on the GAD-7, a validated instrument developed by Drs. Robert L. Spitzer, Janet B.W. Williams, Kurt Kroenke, and colleagues. It is not a diagnosis. Only a licensed mental health professional can diagnose an anxiety disorder. If you are in crisis, call or text 988.
Feeling nervous, anxious, or on edge.(Required)
Not being able to stop or control worrying.(Required)
Worrying too much about different things.(Required)
Trouble relaxing.(Required)
Being so restless that it is hard to sit still.(Required)
Becoming easily annoyed or irritable.(Required)
Feeling afraid, as if something awful might happen.(Required)
If you checked off any problems, how difficult have these problems made it for you to do your work, take care of things at home, or get along with other people?(Required)
This field is hidden when viewing the form

What the GAD-7 Measures and What it Doesn't

This self-assessment is based on the Generalized Anxiety Disorder-7 (GAD-7), a validated screening instrument developed by Drs. Robert L. Spitzer, Janet B.W. Williams, Kurt Kroenke, and colleagues, with support from Pfizer Inc. It is one of the most widely used anxiety screening tools in clinical practice worldwide.

The GAD-7 measures the frequency of seven core anxiety symptoms over the past two weeks. Each question is scored from 0 (not at all) to 3 (nearly every day), producing a total score between 0 and 21. Higher scores indicate more frequent and intense anxiety symptoms.

Although the GAD-7 was developed to screen specifically for generalized anxiety disorder, research has shown it also performs reasonably well as an initial screen for panic disorder, social anxiety disorder, and post-traumatic stress disorder. A higher score is a signal that something is worth assessing, not a label of which anxiety condition is present.

It is important to understand what this screening does not do. It does not diagnose an anxiety disorder. A diagnosis requires a comprehensive clinical evaluation by a licensed mental health professional, including a review of symptom duration, functional impairment, medical history, and potential co-occurring conditions. The GAD-7 is a starting point, not a conclusion.

At Wellness Hills Mental Health in Chester, NJ, the GAD-7 is one of several tools our clinical team uses during intake assessments. It is always interpreted alongside clinical observation, psychiatric evaluation, and a thorough understanding of how symptoms are affecting daily life.

How to Interpret Your GAD-7 Score

The GAD-7 sorts scores into four severity bands, each reflecting how frequently and intensely anxiety symptoms typically show up at that level. The band itself is a useful reference point, but the more important question is how much those symptoms are interfering with your work, sleep, relationships, and ability to feel at rest.

Score Severity What This Typically Looks Like
0–4 Minimal Symptoms are absent or occasional. Worry feels appropriate to circumstances and does not interfere with daily life.
5–9 Mild Worry, tension, or restlessness is present often enough to notice. Daily responsibilities still possible, often with more effort.
10–14 Moderate Anxiety interfering with concentration, sleep, work, or relationships. Functional impairment becoming clearer.
15–21 Severe Anxiety affecting most areas of daily functioning. Sleep, energy, focus, and physical comfort significantly disrupted. Professional support strongly recommended.

A score of 10 or higher is the clinical threshold most providers use to recommend a full evaluation for an anxiety disorder. Some research suggests a cutoff of 8 may be more sensitive without sacrificing specificity, which is why providers treat any score in the moderate or higher range as worth further assessment.

A score alone does not determine the right level of care for you. Two people with the same score can have very different clinical needs depending on how long symptoms have been present, whether previous treatment has been tried, whether co-occurring conditions like depression, trauma, or substance use are involved, and how much daily functioning has been affected. That context is what a clinical assessment provides.

From Screening to Clinical Assessment

A screening like the GAD-7 measures how often anxiety symptoms have shown up in the past two weeks. What it cannot do is distinguish between generalized anxiety, panic disorder, social anxiety, OCD, and trauma-related anxiety, conditions that look different in a clinical setting and respond to different treatments. That distinction is part of what a professional evaluation provides.

At Wellness Hills, the GAD-7 is one input in a broader intake. Our clinicians weigh how long symptoms have been present, whether anxiety is showing up physically through chest tightness, GI symptoms, muscle tension, or sleep disruption, how it’s affecting work and relationships, what coping strategies have already been tried, and whether depression, trauma, or substance use are also part of the picture.

The recommended level of care, outpatient therapy, an Intensive Outpatient Program, or Partial Care, depends on those layered details, not the screening score alone.

If you scored higher than you thought you would, that’s a signal worth taking seriously. Anxiety has a way of becoming background noise that people learn to live with for years before reaching out. There’s no penalty for taking the next step today.

About the GAD-7

The GAD-7 was developed by Drs. Robert L. Spitzer, Janet B.W. Williams, Kurt Kroenke, and colleagues, with an educational grant from Pfizer Inc. No permission is required to reproduce, translate, display, or distribute the GAD-7. PRIME-MD is a trademark of Pfizer Inc.

The GAD-7 was first published in 2006 in Archives of Internal Medicine (Spitzer et al., “A brief measure for assessing generalized anxiety disorder: the GAD-7”). At a cutoff of 8, the GAD-7 has demonstrated approximately 92% sensitivity and 76% specificity for generalized anxiety disorder. It has also been validated as a useful initial screen for panic disorder, social anxiety disorder, and PTSD.

This screening is provided for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or anxiety treatment. If you are in crisis, call or text 988 or go to your nearest emergency room.

Editorial Standards

Our Editorial Policy

Our editorial standards keep our mental health content accurate, compassionate, and evidence-informed. Articles are developed using credible sources, reviewed for medical accuracy when needed, and regularly updated.

Related Articles

More About Anxiety